newsfilter
← Latest News
PR Newswire·

I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business Updates

I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, exclusively focused on the development of highly differentiated...